Madrigal Pharmaceuticals, Inc. (MDGL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1226395,
    "name": "Madrigal Pharmaceuticals, Inc.",
    "stock_name": "Madrigal Pharmaceuticals, Inc.",
    "full_name": "Madrigal Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/madrigal-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "586.21",
    "chg": 13.06,
    "chgp": "2.28%",
    "dir": 1,
    "prev_price": "573.15",
    "mcapval": "10,114.75",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US5588681057",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "439.14 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/madrigal-pharmaceuticals-inc-1226395-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Madrigal Pharmaceuticals Hits New 52-Week High of $469.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/madrigal-pharmaceuticals-hits-new-52-week-high-of-46995-3674056",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MadrigalPharmac_priceRelatedfactors_3674056.png",
        "date": "2025-11-05 16:50:18",
        "description": "Madrigal Pharmaceuticals, Inc. achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals sector. The company reported a significant increase in stock performance and net sales, demonstrating impressive growth despite being loss-making. High institutional holdings indicate strong investor confidence in its market position."
      },
      {
        "title": "Madrigal Pharmaceuticals Experiences Evaluation Revision Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/madrigal-pharmaceuticals-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-price-gains-3652083",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MadrigalPharmac_technicaldot_3652083.png",
        "date": "2025-10-28 15:43:33",
        "description": "Madrigal Pharmaceuticals, Inc. has recently revised its evaluation amid changing market dynamics. The stock has shown impressive performance over the past year, significantly outperforming the S&P 500. Technical indicators present a mixed outlook, reflecting both bullish and cautious trends as the company continues to navigate the pharmaceutical landscape."
      },
      {
        "title": "Is Madrigal Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-madrigal-pharmaceuticals-inc-technically-bullish-or-bearish-3651442",
        "imagepath": "",
        "date": "2025-10-28 11:43:22",
        "description": "As of 24 October 2025, the technical trend for Madrigal Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish. The Bollinger Bands indicate a mildly bullish stance on both weekly and monthly time frames. However, the KST shows a bullish weekly signal but a mildly bearish monthly signal, and Dow Theory presents a mildly bearish weekly view alongside a bullish monthly perspective. The daily moving averages are mildly bullish. \n\nIn terms of performance, Madrigal has outperformed the S&P 500 significantly over the past year with a return of 107.65% compared to the S&P 500's 16.90%, and over three years with a return of 504.39% against the S&P 500's 78.85%. Overall, the current technical stance is mildly bullish, supported by the weekly MACD and Bollinger Bands, despite mixed signals from other indicators...."
      },
      {
        "title": "Is Madrigal Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-madrigal-pharmaceuticals-inc-technically-bullish-or-bearish-3647893",
        "imagepath": "",
        "date": "2025-10-27 11:54:34",
        "description": "As of 24 October 2025, the technical trend for Madrigal Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish, indicating positive momentum. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, suggesting a potential upward price movement. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness. The Dow Theory indicates a mildly bearish stance on the weekly chart but bullish on the monthly chart, reflecting some uncertainty in the short term. Overall, the moving averages are mildly bullish on the daily timeframe. There is no available return data for comparison with the S&P 500...."
      },
      {
        "title": "Is Madrigal Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-madrigal-pharmaceuticals-inc-technically-bullish-or-bearish-3646431",
        "imagepath": "",
        "date": "2025-10-26 11:29:11",
        "description": "As of 24 October 2025, the technical trend for Madrigal Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, and the monthly MACD is also bullish, indicating positive momentum. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness. The moving averages are mildly bullish on the daily timeframe, while the Bollinger Bands reflect a mildly bullish stance on both weekly and monthly timeframes. Dow Theory presents a mildly bearish view on the weekly but bullish on the monthly.\n\nIn terms of performance, Madrigal has outperformed the S&P 500 significantly over the 1-year (107.65% vs. 16.90%) and 3-year (504.39% vs. 78.85%) periods, but has underperformed in the short term with a -3.96% return over the past week compared to the S&P 500's 1.92% gain. Overall, the current technical stance is mildly bullish, driven by the positive MACD and mo..."
      },
      {
        "title": "Madrigal Pharmaceuticals Hits New 52-Week High of $463.48",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/madrigal-pharmaceuticals-hits-new-52-week-high-of-46348-3588404",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MadrigalPharmac_priceRelatedfactors_3588404.png",
        "date": "2025-10-02 22:39:59",
        "description": "Madrigal Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company has experienced significant growth, with a notable increase in stock performance and net sales, despite currently operating at a loss. High institutional holdings indicate confidence in its fundamentals."
      },
      {
        "title": "Madrigal Pharmaceuticals Achieves 114.43% Annual Growth, Marking It as a Multibagger Stock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/madrigal-pharmaceuticals-achieves-11443-annual-growth-marking-it-as-a-multibagger-stock-3586551",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MadrigalPharmac_multibagger_3586551.png",
        "date": "2025-10-01 17:13:36",
        "description": "Madrigal Pharmaceuticals, Inc. has recently undergone a revision in its score, reflecting its strong market performance and impressive financial metrics. The stock has outperformed the S&P 500 significantly over the past year, with remarkable growth in net sales and high institutional holdings, indicating robust investor confidence."
      },
      {
        "title": "Madrigal Pharmaceuticals Hits New 52-Week High of $460.00",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/madrigal-pharmaceuticals-hits-new-52-week-high-of-46000-3586068",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MadrigalPharmac_priceRelatedfactors_3586068.png",
        "date": "2025-10-01 16:43:21",
        "description": "Madrigal Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company reported a remarkable growth in net sales and has posted positive results for two consecutive quarters, supported by high institutional holdings, indicating strong investor confidence."
      },
      {
        "title": "Madrigal Pharmaceuticals Hits Day High with 8.43% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/madrigal-pharmaceuticals-hits-day-high-with-843-surge-in-stock-price-3585915",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MadrigalPharmac_priceRelatedfactors_3585915.png",
        "date": "2025-10-01 16:20:06",
        "description": "Madrigal Pharmaceuticals, Inc. has seen a notable stock increase today, reaching an intraday high of USD 460.00. The company reported a remarkable 1353.76% rise in net sales in June and has shown strong operational performance with positive results over the last two quarters, supported by high institutional holdings."
      }
    ],
    "total": 17,
    "sid": "1226395",
    "stock_news_url": "https://www.marketsmojo.com/news/madrigal-pharmaceuticals-inc-1226395"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Madrigal Pharmaceuticals Hits New 52-Week High of $469.95

2025-11-05 16:50:18

Madrigal Pharmaceuticals, Inc. achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals sector. The company reported a significant increase in stock performance and net sales, demonstrating impressive growth despite being loss-making. High institutional holdings indicate strong investor confidence in its market position.

Madrigal Pharmaceuticals Experiences Evaluation Revision Amid Strong Market Performance

2025-10-28 15:43:33

Madrigal Pharmaceuticals, Inc. has recently revised its evaluation amid changing market dynamics. The stock has shown impressive performance over the past year, significantly outperforming the S&P 500. Technical indicators present a mixed outlook, reflecting both bullish and cautious trends as the company continues to navigate the pharmaceutical landscape.

Is Madrigal Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-28 11:43:22

As of 24 October 2025, the technical trend for Madrigal Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish. The Bollinger Bands indicate a mildly bullish stance on both weekly and monthly time frames. However, the KST shows a bullish weekly signal but a mildly bearish monthly signal, and Dow Theory presents a mildly bearish weekly view alongside a bullish monthly perspective. The daily moving averages are mildly bullish. In terms of performance, Madrigal has outperformed the S&P 500 significantly over the past year with a return of 107.65% compared to the S&P 500's 16.90%, and over three years with a return of 504.39% against the S&P 500's 78.85%. Overall, the current technical stance is mildly bullish, supported by the weekly MACD and Bollinger Bands, despite mixed signals from other indicators....

Is Madrigal Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-27 11:54:34

As of 24 October 2025, the technical trend for Madrigal Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the monthly MACD is also bullish, indicating positive momentum. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, suggesting a potential upward price movement. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness. The Dow Theory indicates a mildly bearish stance on the weekly chart but bullish on the monthly chart, reflecting some uncertainty in the short term. Overall, the moving averages are mildly bullish on the daily timeframe. There is no available return data for comparison with the S&P 500....

Is Madrigal Pharmaceuticals, Inc. technically bullish or bearish?

2025-10-26 11:29:11

As of 24 October 2025, the technical trend for Madrigal Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, and the monthly MACD is also bullish, indicating positive momentum. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness. The moving averages are mildly bullish on the daily timeframe, while the Bollinger Bands reflect a mildly bullish stance on both weekly and monthly timeframes. Dow Theory presents a mildly bearish view on the weekly but bullish on the monthly. In terms of performance, Madrigal has outperformed the S&P 500 significantly over the 1-year (107.65% vs. 16.90%) and 3-year (504.39% vs. 78.85%) periods, but has underperformed in the short term with a -3.96% return over the past week compared to the S&P 500's 1.92% gain. Overall, the current technical stance is mildly bullish, driven by the positive MACD and mo...

Madrigal Pharmaceuticals Hits New 52-Week High of $463.48

2025-10-02 22:39:59

Madrigal Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company has experienced significant growth, with a notable increase in stock performance and net sales, despite currently operating at a loss. High institutional holdings indicate confidence in its fundamentals.

Madrigal Pharmaceuticals Achieves 114.43% Annual Growth, Marking It as a Multibagger Stock

2025-10-01 17:13:36

Madrigal Pharmaceuticals, Inc. has recently undergone a revision in its score, reflecting its strong market performance and impressive financial metrics. The stock has outperformed the S&P 500 significantly over the past year, with remarkable growth in net sales and high institutional holdings, indicating robust investor confidence.

Madrigal Pharmaceuticals Hits New 52-Week High of $460.00

2025-10-01 16:43:21

Madrigal Pharmaceuticals, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company reported a remarkable growth in net sales and has posted positive results for two consecutive quarters, supported by high institutional holdings, indicating strong investor confidence.

Madrigal Pharmaceuticals Hits Day High with 8.43% Surge in Stock Price

2025-10-01 16:20:06

Madrigal Pharmaceuticals, Inc. has seen a notable stock increase today, reaching an intraday high of USD 460.00. The company reported a remarkable 1353.76% rise in net sales in June and has shown strong operational performance with positive results over the last two quarters, supported by high institutional holdings.

View All News